Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
VGL | Ann: Notice of Annual Meeting | 19/04/24 | 0 | 62 | |||
|
|||||||
VGL | Ann: SPH Notice - Pinnacle Investment Management Group Limited | 18/04/24 | 0 | 37 | |||
|
|||||||
VGL | Ann: ASX Appendix 3H | 16/04/24 | 0 | 63 | |||
|
|||||||
VGL | Ann: Ongoing Disclosure Notices | 15/04/24 | 0 | 52 | |||
|
|||||||
VGL | Ann: VGL - Capital Change Notice | 15/04/24 | 0 | 59 | |||
|
|||||||
VGL | Ann: VGL - Capital Change Notice | 08/04/24 | 0 | 53 | |||
|
|||||||
VGL | Ann: SPH Notice - Accident Compensation Corporation (ACC) | 19/03/24 | 0 | 62 | |||
|
|||||||
VGL | Ann: VGL - 2024 Annual Meeting and Director Nominations | 14/03/24 | 0 | 79 | |||
|
See All Discussions